Benjamin Ferland
Papers
1
Total Citations
7
H-Index
1
About
Benjamin Ferland is a pioneering translational researcher in thoracic oncology, whose work centers on precision medicine for non-small cell lung cancer (NSCLC). His most significant contribution is the first-in-human proof-of-concept study demonstrating the safety and feasibility of implanting multidrug-eluting microdevices directly into lung tumors during surgery. This innovative approach allows for in situ chemotherapeutic sensitivity testing, enabling real-time assessment of drug efficacy within a patient’s own tumor microenvironment—a breakthrough that could revolutionize personalized adjuvant therapy. Ferland’s landmark 2022 paper, cited 7 times, provides the foundational evidence for this technology, addressing the critical challenge of predicting optimal treatment regimens to improve postsurgical outcomes. His work bridges surgical oncology and drug development, offering a novel platform to bypass traditional trial-and-error prescribing. By validating the implantation and retrieval of these microdevices in NSCLC patients, Ferland has opened a new frontier in functional precision oncology, with potential to spare patients from ineffective therapies and accelerate the identification of effective drug combinations.
Research Focus
Key Achievements
Top Papers
- 1